New device to reduce the need for temporary ostomies in rectal cancer patients
Safety and Efficacy Trial of the ColoSeal ICD System for the Treatment of Rectal Cancer Patients
This study is testing a new, less invasive device that could help people with rectal cancer avoid the need for temporary ostomies, making their treatment easier and improving their quality of life.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Savage Medical NIH-funded |
| Lab location | 1 site (Belmont, United States) |
| Project ID | NIH-11007069 on NIH RePORTER |
What this research studies
This research investigates a new minimally-invasive medical device designed to replace the need for temporary ostomies in patients undergoing treatment for rectal cancer. The device aims to minimize the complications and negative impacts associated with traditional ostomy surgeries, which are often necessary for rectal cancer patients. By using this innovative technology, the goal is to allow the majority of patients to avoid the burdensome process of ostomy creation and reversal, thereby improving their quality of life during cancer treatment. The study will assess the safety and efficacy of this device in a clinical setting.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with rectal cancer who are facing surgical treatment options.
Not a fit: Patients who have already undergone permanent ostomy surgery or those with advanced rectal cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life for rectal cancer patients by reducing the need for temporary ostomies.
How similar studies have performed: Similar approaches in minimizing surgical interventions for cancer patients have shown promise, but this specific device represents a novel solution.
Where this research is happening
Belmont, United States
- Savage Medical — Belmont, United States (Active)
Researchers
- Principal investigator: Fong, Kenton Dodyan — Savage Medical
- Study coordinator: Fong, Kenton Dodyan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.